Company research
Healthcare Triangle, Inc.
CIK 1839285Updated Sep 27, 2026
HCTI price & chart
Loading TradingView…
NASDAQ:HCTI on TradingView ↗About the company
Healthcare Triangle, Inc. delivers advanced digital transformation, artificial intelligence, and cloud-infrastructure solutions for healthcare providers, payers, and life sciences organizations. HCTI strengthens healthcare delivery through enhanced security, compliance, data analytics, and operational efficiency.
In the news
Healthcare Triangle, Inc. to Distribute Minority Interest of Teyame AI Holdings Inc. Common Shares in Stock Dividend Distribution to HCTI Shareholders, In Connection with its Planned Direct Listing. ↗
Recent filings
POS AM filing
Entry into a Material Definitive Agreement
Items 1.01, 9.01
Entry into a Material Definitive Agreement
Items 1.01, 9.01
10-Q filing
Unregistered Sales of Equity Securities · Regulation FD Disclosure
Items 3.02, 7.01, 9.01
Show 5 more recent filings
Financials
FY 2025 · USDSource
Source
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 22,736,000Source | 1,961,000Source | 6,858,000Source | 20,763,000Source |
| Property, Plant and Equipment, NetUSD | 5,000Source | 12,000Source | 44,000Source | 80,000Source |
| GoodwillUSD | 2,946,000Source | — | — | 1,289,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | — | — | 857,000Source | — |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 7,625,000Source | 20,000Source | 1,234,000Source | 1,341,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 2,070,000Source | 1,110,000Source | 3,595,000Source | 5,592,000Source |
| Assets, CurrentUSD | 13,151,000Source | 1,452,000Source | 5,653,000Source | 7,749,000Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | — | 7,075,000Source | 8,249,000Source | 8,375,000Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | — | 7,435,000Source | — | — |
| Common Stock, Value, IssuedUSD | 11,000Source | — | 0Source | 0Source |
| Additional Paid in CapitalUSD | 45,534,000Source | 21,022,000Source | 26,211,000Source | 24,956,000Source |
| Retained Earnings (Accumulated Deficit)USD | -42,999,000Source | -33,571,000Source | -27,602,000Source | -12,568,000Source |
| Stockholders' Equity Attributable to ParentUSD | — | -5,114,000Source | -1,391,000Source | 12,478,000Source |
| Liabilities and EquityUSD | 22,736,000Source | 1,961,000Source | 6,858,000Source | 20,763,000Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 12,792,000Source | 7,075,000Source | 7,652,000Source | 6,148,000Source |
| Accounts Payable, CurrentUSD | 744,000Source | 2,539,000Source | 1,953,000Source | 1,481,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | -37,000Source | — | — | — |
| Additional Financial Items | ||||
| Accounts Receivable, after Allowance for Credit LossUSD | — | — | — | 5,592,000Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -401,000Source | -9,609,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 705,000Source | 889,000Source | 1,566,000Source | 3,374,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 451,000Source | 87,000Source | 166,000Source | — |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 913,000Source | -2,315,000Source | -2,270,000Source | -4,081,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -16,523,000Source | -1,081,000Source | -2,151,000Source | -2,600,000Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -1,751,000Source | — | -12,000Source | -3,319,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 6,000Source | — | 12,000Source | — |
| Cash flows from financing activities: | ||||
| Payments for Repurchase of Common StockUSD | — | — | — | 142,000Source |
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 25,879,000Source | -133,000Source | 2,056,000Source | 5,490,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 7,625,000Source | 20,000Source | 1,234,000Source | 1,341,000Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | 121,000Source | 968,000Source | — |
| Income Taxes Paid, NetUSD | — | 12,000Source | 35,000Source | — |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 451,000Source | 0Source | — | 257,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 223,000Source | — | 435,000,000Source | — |
| Amortization of Intangible AssetsUSD | — | 857,000Source | 1,518,000Source | 3,167,000Source |
| AssetAcquisitionContingentConsiderationLiabilityUSD | — | — | — | 2,227,000Source |
| DepreciationUSD | 13,000Source | 32,000Source | 48,000Source | 35,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | 41,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -18,000Source | — | — | — |
| General and Administrative ExpenseUSD | 7,337,000Source | 3,950,000Source | 5,727,000Source | 5,575,000Source |
| GoodwillUSD | 2,946,000Source | — | — | 1,289,000Source |
| Goodwill, Impairment LossUSD | — | 0Source | 2,385,000Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | 9,789,000Source | — | — | -10,414,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -37,000Source | — | -35,000Source | — |
| Income Tax Expense (Benefit)USD | — | 12,000Source | 35,000Source | 63,000Source |
| Net Income (Loss) Attributable to ParentUSD | -9,476,000Source | -5,969,000Source | -8,686,000Source | -9,610,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -37,000Source | — | — | — |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 9,428,000Source | — | -8,686,000Source | -9,609,000Source |
| Operating ExpensesUSD | 11,679,000Source | 7,641,000Source | 14,472,000Source | 21,711,000Source |
| Proceeds from Issuance of Common StockUSD | 9,825,000Source | — | 500,000Source | 5,888,000Source |
| Proceeds from Stock Options ExercisedUSD | — | — | 0Source | 29,000Source |
| Financing Receivable, Credit Loss, Expense (Reversal)USD | 17,000Source | — | — | — |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | — | 45,886,000Source |
| Unrealized Gain (Loss) on InvestmentsUSD | 27,000Source | — | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 13,891,000Source | 11,696,000Source | 33,203,000Source | 45,886,000Source |
| Cost of Goods and Services Sold | — | — | — | — |
| Selling, General and Administrative ExpenseUSD | — | — | — | 0Source |
| Operating Income (Loss)USD | -9,789,000Source | -4,751,000Source | -7,695,000Source | -10,416,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -9,476,000Source | -5,957,000Source | -8,651,000Source | -9,547,000Source |
| Income Tax Expense (Benefit)USD | — | 12,000Source | 35,000Source | 63,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | -37,000Source | — | — | — |
| Net Income (Loss) Attributable to ParentUSD | -9,476,000Source | -5,969,000Source | -8,686,000Source | -9,610,000Source |
| Earnings Per Share, BasicUSD per share | -152.3Source | -1.13Source | -2.08Source | — |
| Earnings Per Share, DilutedUSD per share | -152.3Source | -1.13Source | -2.08Source | — |
| Weighted Average Number of Shares Outstanding, Basicshares | 61,873Source | 5,278,293Source | 4,179,140Source | — |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 61,873Source | 5,278,293Source | 4,179,140Source | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | — | 857,000Source | 1,518,000Source | 3,167,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | 0Source | 63,000Source |
| Depreciation, Depletion and Amortization, NonproductionUSD | 705,000Source | — | 1,566,000Source | 3,374,000Source |
| Fair Value, Option, Changes in Fair Value, Gain (Loss)USD | 41,000Source | — | — | — |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | -18,000Source | — | — | — |
| General and Administrative ExpenseUSD | 7,337,000Source | 3,950,000Source | 5,727,000Source | 5,575,000Source |
| Goodwill, Impairment LossUSD | — | 0Source | 2,385,000Source | — |
| Gross ProfitUSD | 1,235,000,000Source | 1,070,000,000Source | 1,070,000,000Source | — |
| Income (Loss) Attributable to Parent, before TaxUSD | — | — | -8,651,000Source | — |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to ParentUSD | 9,789,000Source | — | — | -10,414,000Source |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling InterestUSD | -37,000Source | — | -35,000Source | — |
| Interest ExpenseUSD | 567,000Source | — | — | 212,000Source |
| Interest Expense, DebtUSD | — | — | 968,000Source | 211,000Source |
| Interest Income (Expense), NetUSD | -567,000Source | -1,213,000Source | -968,000Source | -212,000Source |
| Marketing and Advertising ExpenseUSD | — | — | — | 6,808,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | 9,428,000Source | — | -8,686,000Source | -9,609,000Source |
| Operating ExpensesUSD | 11,679,000Source | 7,641,000Source | 14,472,000Source | 21,711,000Source |
| Other ExpensesUSD | 1,215,000Source | — | — | — |
| Other IncomeUSD | 857,000Source | 7,000Source | 12,000Source | 1,081,000Source |
| Research and Development ExpenseUSD | 536,000Source | 429,000Source | 799,000Source | 5,953,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | — | 45,886,000Source |
| Selling and Marketing ExpenseUSD | 3,084,000Source | 2,203,000Source | 4,670,000Source | — |
Offerings
Registration 333-297397
Filing attachments
ea029955101ex99-1.htm · 8-K · 2026-07-29
EX-99.1 2 ea029955101ex99-1.htm PRICING PRESS RELEASE DATED JULY 29, 2026 Exhibit 99.1 Healthcare Triangle Completes Share Issuances Relating to Legacy M&A Transactions, Strengthening Compliance With Nasdaq’s New $5 Million Market Value Listing Standard Common shares outstanding increase to 14,644,322 following the closing of two previously approved transactions, providing added cushion under Nasdaq’s newly effective Market Value of Listed Securities (MVLS) requirement PLEASANTON, Calif. …
Read attachment ↗ea029478001ex4-1.htm · 8-K · 2026-06-15
EX-4.1 2 ea029478001ex4-1.htm FORM OF ORIGINAL ISSUE DISCOUNT SENIOR CONVERTIBLE PROMISSORY NOTE DUE DECEMBER 12, 2026 Exhibit 4.1 NEITHER THIS SECURITY NOR THE SECURITIES INTO WHICH THIS SECURITY IS CONVERTIBLE HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURSUAN…
Read attachment ↗ea029478001ex4-2.htm · 8-K · 2026-06-15
EX-4.2 3 ea029478001ex4-2.htm COMMON STOCK PURCHASE WARRANT ISSUED TO HUDSON GLOBAL VENTURES, LLC, DATED JUNE 12, 2026 Exhibit 4.2 NEITHER THIS SECURITY NOR THE SECURITIES AS TO WHICH THIS SECURITY MAY BE EXERCISED HAVE BEEN REGISTERED WITH THE SECURITIES AND EXCHANGE COMMISSION OR THE SECURITIES COMMISSION OF ANY STATE IN RELIANCE UPON AN EXEMPTION FROM REGISTRATION UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), AND, ACCORDINGLY, MAY NOT BE OFFERED OR SOLD EXCEPT PURS…
Read attachment ↗ea029478001ex99-1.htm · 8-K · 2026-06-15
EX-99.1 7 ea029478001ex99-1.htm PRESS RELEASE, DATED JUNE 12, 2026 Exhibit 99.1 Healthcare Triangle, Inc. Announces Closing of Private Placement Offering of Original Issue Discount Senior Convertible Promissory Notes for Gross Proceeds of Approximately $3.6 Million PLEASANTON, Calif., June 12, 2026 (PR NEWSWIRE) - Healthcare Triangle, Inc. (Nasdaq: HCTI) (“HCTI” or the “Company”), a leader in digital transformation solutions for healthcare and life sciences, today announces the closing of…
Read attachment ↗